Evommune EVMN Derivative Gain Loss On Derivative Net
Derivative Gain Loss On Derivative Net at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:DerivativeGainLossOnDerivativeNet.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's derivative gain loss on derivative net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's derivative gain loss on derivative net?
- Evommune (EVMN) reported derivative gain loss on derivative net of $25.37K in Q1 2026.
- How has Evommune 's derivative gain loss on derivative net changed year-over-year?
- Evommune 's derivative gain loss on derivative net decreased by 98.6% year-over-year, from $1.84M to $25.37K.
- What does derivative gain loss on derivative net mean?
- The net impact of changes in the fair value of derivative instruments held by the company, recognized in the income statement. This captures the volatility associated with financial instruments that are sensitive to market conditions or the company's own stock price. It is essential for evaluating the impact of non-operating financial risks on overall net income.